(Q39602481)

13 September 2017

Anthelmintic discovery and development in the animal health industry (English)

1 reference

13 September 2017

Debra J Woods

1

1 reference

13 September 2017

Christelle Lauret

series ordinal

2

1 reference

13 September 2017

Timothy Geary

series ordinal

3

1 reference

13 September 2017

language of work or name

English

0 references

publication date

1 October 2007

1 reference

Expert Opinion on Drug Discovery

13 September 2017

1 reference

13 September 2017

2

1 reference

13 September 2017

s1

1 reference

13 September 2017

S25-33

1 reference

13 September 2017

Ivermectin: an update

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2.S1.S25

Ivermectin 20 years on: maturation of a wonder drug

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2.S1.S25

The changing landscape of antiparasitic drug discovery for veterinary medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2.S1.S25

Lymphatic filariasis elimination: progress in global programme development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2.S1.S25

Mechanism-based screening: discovery of the next generation of anthelmintics depends upon more basic research

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2.S1.S25

Development of antiparasitic drugs in the 21st century.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2.S1.S25

Genomic filtering: an approach to discovering novel antiparasitics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2.S1.S25

Model-organism genomics in veterinary parasite drug-discovery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2.S1.S25

Nematode neuropeptide receptors and their development as anthelmintic screens

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2.S1.S25

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2.S1.S25

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2.S1.S25

Nitazoxanide, a broad-spectrum thiazolide anti-infective agent for the treatment of gastrointestinal infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2.S1.S25

Field evaluation of the efficacy and safety of emodepside/praziquantel spot-on solution against naturally acquired nematode and cestode infections in domestic cats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2.S1.S25

Marcfortine and paraherquamide class of anthelmintics: discovery of PNU-141962.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2.S1.S25

Novel thiophenes and analogues with anthelmintic activity against Haemonchus contortus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2.S1.S25

Synthesis and anthelmintic properties of arylquinolines with activity against drug-resistant nematodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2.S1.S25

Syntheses of 2,4,6-trisubstituted pyrimidine derivatives as a new class of antifilarial topoisomerase II inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2.S1.S25

Synthesis and biological evaluation of simplified mycothiazole analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2.S1.S25

Innovative lead discovery strategies for tropical diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17460441.2.S1.S25

10.1517/17460441.2.S1.S25

21 January 2018

Identifiers

DOI

1 reference

13 September 2017

1 reference